Skip to search formSkip to main contentSkip to account menu

Cymbalta

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Over the past half century, we have witnessed many major breakthroughs in basic neuroscience research that have enriched our… 
Review
2013
Review
2013
Selection of an antidepressant medication is based on various factors, such as safety, tolerability, and cost. This article… 
2013
2013
FDA announced that it had given approval to several pharmaceutical companies to market duloxetine delayed-release capsules… 
2013
2013
Background: The safety and pattern of use of a medicinal product cannot be fully studied prior to its marketing. In Denmark, the… 
2013
2013
Abstract Background: Duloxetine is a potent and balanced dual inhibitor of serotonin and norepinephrine reuptake that is being… 
2012
2012
Patient #1 A 22-year-old African American male presented with abdominal pain and coffee ground vomitus after allegedly swallowing… 
2012
2012
Duloxetine (Cymbalta) is a potent serotonin norepinephrine reuptake inhibitor used for the management of major depression and… 
2010
2010
Les antidepresseurs sont le traitement classique des troubles depressits et anxieux. oncologie, outre ces indications princeps… 
2007
2007
Neuromidin (ipidacrin) was administered to 41 patients, aged 51-79 years, with mild cognitive impairment (MSI) (19) and vascular… 
Review
2006
Review
2006
Duloxetine (Cymbalta is an antidepressant of the class of serotonin noradrenaline reuptake inhibitors. The efficacy of duloxetine…